Cargando…

Incidence of COVID-19 among individuals vaccinated with ChAdOx1 nCoV-19 vaccine (recombinant) against SARS-CoV-2 at a tertiary health care centre in Telangana

Detalles Bibliográficos
Autores principales:	Kokiwar, Prashant Ramdas, Reddy, Bhadra, Reddy, Preeti, Gowrav, Siddappa, Shirole, Chandrakant
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Research Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552396/ https://www.ncbi.nlm.nih.gov/pubmed/35859447 http://dx.doi.org/10.4103/ijmr.ijmr_1626_21

Ejemplares similares

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
por: Lodge, Archie
Publicado: (2020)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
por: Chauhan, Anil, et al.
Publicado: (2020)

Depression following ChAdOx1-S/nCoV-19 vaccine
por: Uvais, N.A.
Publicado: (2022)

Reversible radiculomyelitis after ChAdOx1 nCoV-19 vaccination
por: Spataro, Rossella, et al.
Publicado: (2022)

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
por: Schultz, Nina H., et al.
Publicado: (2021)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply
por: Voysey, Merryn, et al.
Publicado: (2020)

Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine
por: Rogawski McQuade, Elizabeth T, et al.
Publicado: (2021)

Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination
por: Normark, Johan, et al.
Publicado: (2021)

Takotsubo (stress) cardiomyopathy after ChAdOx1 nCoV-19 vaccination
por: Crane, Phillip, et al.
Publicado: (2021)

Thrombotic thrombocytopenic purpura after ChAdOx1 nCoV-19 vaccine
por: Lee, Hui Ping, et al.
Publicado: (2021)

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
por: Ogbe, Ane, et al.
Publicado: (2022)

Post ChAdOx1 nCoV-19 vaccination frontal lobe syndrome
por: Tapdia, Madhusudan, et al.
Publicado: (2022)

Autonomic dysfunction post-inoculation with ChAdOx1 nCoV-19 vaccine
por: Karimi Galougahi, Keyvan
Publicado: (2021)

Transient cryoglobulinaemic vasculitis following ChAdOx1 nCoV-19 vaccine
por: Ahmer, Sadaf, et al.
Publicado: (2022)

Immunogenicity of the ChAdOx1 nCoV-19 vaccine in patients with hematologic malignancies
por: Thookhamme, Chayapa, et al.
Publicado: (2023)

Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination
por: Sheng, Wang-Huei, et al.
Publicado: (2022)

Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination
por: Schmidt, Tina, et al.
Publicado: (2021)

Pancreas allograft rejection occurring after ChAdOx1 nCoV-19 vaccine
por: Masset, Christophe, et al.
Publicado: (2022)

Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association?
por: Vegezzi, Elisa, et al.
Publicado: (2021)

Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine
por: Shahrigharahkoshan, Shaghayegh, et al.
Publicado: (2021)

Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
por: Gabarin, Nadia, et al.
Publicado: (2021)

IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19
por: Badier, Laure, et al.
Publicado: (2021)

Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia
por: Greinacher, Andreas, et al.
Publicado: (2021)

Adult-Onset Still’s Disease After the ChAdOx1 nCoV-19 Vaccine
por: AlQudari, Elham A, et al.
Publicado: (2022)

Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
por: Chang, Jer-Hwa, et al.
Publicado: (2022)

A case report of ChAdOx1 nCoV-19 vaccine–associated encephalitis
por: Takata, Junko, et al.
Publicado: (2021)

Subclinical thrombotic thrombocytopenic purpura after vaccination with ChAdOx1 nCoV-19
por: Jang, Hee Ryeong, et al.
Publicado: (2021)

Zona après l’administration du vaccin ChAdOx1 nCoV-19
por: Sarah, Sarah, et al.
Publicado: (2021)

Chronic Inflammatory Demyelinating Polyneuropathy after ChAdOx1 nCoV-19 Vaccination
por: Bagella, Caterina Francesca, et al.
Publicado: (2021)

Impact of ChAdOx1 nCoV-19 (Covishield™) Vaccination: How Long Will It Persist?
por: Devi, Leimapokpam Sumitra, et al.
Publicado: (2022)

Healthcare professionals & adverse events of ChAdOx1 nCoV-19 coronavirus vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Longitudinally extensive transverse myelitis following ChAdOx1 nCoV-19 vaccine
por: Shetty, AJ, et al.
Publicado: (2022)

ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

Nephrotic Syndrome Following ChAdOx1 nCoV-19 Vaccine Against SARScoV-2
por: Anupama, Y.J., et al.
Publicado: (2021)

Vaccine Breakthrough Infections by SARS-CoV-2 Variants after ChAdOx1 nCoV-19 Vaccination in Healthcare Workers
por: Kale, Pratibha, et al.
Publicado: (2021)

Notice of addendum to Article reporting Oxford trial of ChAdOx1 nCoV-19 vaccine
por: Pollard, Andrew J
Publicado: (2020)

A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
por: Kim, Gyungah, et al.
Publicado: (2021)

New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine
por: Aladdin, Yasser, et al.
Publicado: (2021)

Vaccine‐induced immune thrombotic thrombocytopenia with ChAdOx1 nCoV‐19 is rare in Asia
por: Boonyawat, Kochawan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_imcp3bctf5aa1nib11p2cp92aq